Skip to main content
Log in

Dabigatran malabsorption in amiodarone-induced thyrotoxicosis: a clinical report

  • CE-LETTER TO THE EDITOR
  • Published:
Internal and Emergency Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Ruff CT, Giugliano RP, Braunwald E, Hoffman EB, Deenadayalu N, Ezekowitz MD, Camm AJ, Weitz JI, Lewis BS, Parkhomenko A, Yamashita T, Antman EM (2014) Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials. Lancet 383:955–962

    Article  CAS  PubMed  Google Scholar 

  2. Martino E, Bartalena L, Bogazzi F, Braverman LE (2001) The effects of amiodarone on the thyroid. Endocr Rev 22:240–254

    CAS  PubMed  Google Scholar 

  3. Bahn Chair RS, Burch HB, Cooper DS, Garber JR, Greenlee MC, Klein I, Laurberg P, McDougall IR, Montori VM, Rivkees SA, Ross DS, Sosa JA, Stan MN, American Thyroid Association; American Association of Clinical Endocrinologists (2011) Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists. Thyroid 21:593–646

    Article  PubMed  Google Scholar 

  4. Stangier J (2008) Clinical pharmacokinetics and pharmacodynamics of the oral direct thrombin inhibitor dabigatran etexilate. Clin Pharmacokinet 47:285–295

    Article  CAS  PubMed  Google Scholar 

  5. Douros A, Schlemm L, Bolbrinker J, Ebinger M, Kreutz R (2014) Insufficient anticoagulation with dabigatran in a patient with short bowel syndrome. Thromb Haemost 112:419–420

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

The authors thank Dr. Laura Sabatino for her helpful editing.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Francesco Sbrana.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Statement of human rights

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained by all individual participants included in the study.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sbrana, F., Genovesi, D., Catapano, G.A. et al. Dabigatran malabsorption in amiodarone-induced thyrotoxicosis: a clinical report. Intern Emerg Med 11, 889–890 (2016). https://doi.org/10.1007/s11739-016-1434-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11739-016-1434-6

Keywords

Navigation